<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(6)</volume><submitter>Song X</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Obesity has been considered as a leading cause of multiple metabolic syndromes, such as type 2 diabetes and hypertension cardiovascular diseases. Jian Pi Tiao Gan Yin (JPTGY), a Chinese herb preparation, is used to treat obesity of liver qi stagnation and spleen deficiency. The mechanism of action of JPTGY in obesity remains unclear. This study evaluated the effect of JPTGY on obesity.&lt;h4>Methods&lt;/h4>The mechanism of action of JPTGY on obesity was investigated in high-fat diet (HFD)-induced obese mice and palmitic acid-treated 3T3-L1 cells. Lipid droplet accumulation was detected using oil red O staining. Factors associated with lipid accumulation were detected by western blotting.&lt;h4>Results&lt;/h4>Treatment with JPTGY reduced HFD-induced adiposity and body weight gain. JP</pubmed_abstract><journal>Annals of translational medicine</journal><pagination>291</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9011225</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Jian Pi Tiao Gan Yin alleviates obesity phenotypes through mTORC1/SREBP1 signaling &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>.</pubmed_title><pmcid>PMC9011225</pmcid><pubmed_authors>Tian M</pubmed_authors><pubmed_authors>Han L</pubmed_authors><pubmed_authors>Lin X</pubmed_authors><pubmed_authors>Sun F</pubmed_authors><pubmed_authors>Song X</pubmed_authors><pubmed_authors>Feng B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Jian Pi Tiao Gan Yin alleviates obesity phenotypes through mTORC1/SREBP1 signaling &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>.</name><description>&lt;h4>Background&lt;/h4>Obesity has been considered as a leading cause of multiple metabolic syndromes, such as type 2 diabetes and hypertension cardiovascular diseases. Jian Pi Tiao Gan Yin (JPTGY), a Chinese herb preparation, is used to treat obesity of liver qi stagnation and spleen deficiency. The mechanism of action of JPTGY in obesity remains unclear. This study evaluated the effect of JPTGY on obesity.&lt;h4>Methods&lt;/h4>The mechanism of action of JPTGY on obesity was investigated in high-fat diet (HFD)-induced obese mice and palmitic acid-treated 3T3-L1 cells. Lipid droplet accumulation was detected using oil red O staining. Factors associated with lipid accumulation were detected by western blotting.&lt;h4>Results&lt;/h4>Treatment with JPTGY reduced HFD-induced adiposity and body weight gain. JP</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-19T23:17:03.823Z</modification><creation>2025-04-19T23:17:03.823Z</creation></dates><accession>S-EPMC9011225</accession><cross_references><pubmed>35433951</pubmed><doi>10.21037/atm-22-685</doi></cross_references></HashMap>